Known targets — ChEMBL curated mechanism
KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2
The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 20/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanidine SCHEMBL3085754 | 1.00 | MC4R (0.93) | MC4R | |
| SCHEMBL3077948 | 0.90 | MC4R (0.88) | MC4R | |
| SCHEMBL3077963 | 0.90 | MC4R (0.88) | MC4R | |
| SCHEMBL3089287 | 0.90 | MC4R (0.82) | MC4R | |
| SCHEMBL3080663 | 0.88 | MC4R (0.84) | MC4R | |
| SCHEMBL3080662 | 0.88 | MC4R (0.84) | MC4R | |
| SCHEMBL14193780 | 0.85 | MC4R (0.75) | MC4R | |
| SCHEMBL3819524 | 0.84 | MC4R (1.00) | MC4R | |
| SCHEMBL3089293 | 0.84 | MC4R (1.00) | MC4R | |
| SCHEMBL13146927 | 0.84 | MC4R (0.77) | MC4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1590338-B1 | MODULATORS OF MELANOCORTIN RECEPTOR | ORE PHARMACEUTICALS INC (US) | 2009-08-26 | — | — | EP | disclosed |